These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 9150376

  • 1. Antiedematous effects of combination therapies with the leukotriene synthesis inhibitor BAY X 1005 in the archidonic acid-induced mouse ear inflammation test.
    Burchardt ER, Müller-Peddinghaus R.
    Prostaglandins Leukot Essent Fatty Acids; 1997 Apr; 56(4):301-6. PubMed ID: 9150376
    [Abstract] [Full Text] [Related]

  • 2. Favorable combination effects of the leukotriene synthesis inhibitor BAY X 1005 and dexamethasone on edema formation in the arachidonic acid-induced mouse ear inflammation test.
    Burchardt ER, Müller-Peddinghaus R.
    Prostaglandins Leukot Essent Fatty Acids; 1999 Jan; 60(1):5-11. PubMed ID: 10319912
    [Abstract] [Full Text] [Related]

  • 3. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
    Horizoe T, Nagakura N, Chiba K, Shirota H, Shinoda M, Kobayashi N, Numata H, Okamoto Y, Kobayashi S.
    Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of leukotriene synthesis inhibitors in models of acute and chronic inflammation.
    Nickerson-Nutter CL, Medvedeff ED.
    Arthritis Rheum; 1996 Mar; 39(3):515-21. PubMed ID: 8607901
    [Abstract] [Full Text] [Related]

  • 6. Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents.
    Carlson RP, O'Neill-Davis L, Chang J, Lewis AJ.
    Agents Actions; 1985 Dec; 17(2):197-204. PubMed ID: 3938181
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Potential anti-inflammatory effects of 5-lipoxygenase inhibition--exemplified by the leukotriene synthesis inhibitor BAY X 1005.
    Müller-Peddinghaus R.
    J Physiol Pharmacol; 1997 Dec; 48(4):529-36. PubMed ID: 9444606
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacological Characterization of the Edema Caused by Vitalius dubius (Theraphosidae, Mygalomorphae) Spider Venom in Rats.
    Rocha-E-Silva TA, Linardi A, Antunes E, Hyslop S.
    J Pharmacol Exp Ther; 2016 Jan; 356(1):13-9. PubMed ID: 26607257
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibitory effects of black tea theaflavin derivatives on 12-O-tetradecanoylphorbol-13-acetate-induced inflammation and arachidonic acid metabolism in mouse ears.
    Huang MT, Liu Y, Ramji D, Lo CY, Ghai G, Dushenkov S, Ho CT.
    Mol Nutr Food Res; 2006 Feb; 50(2):115-22. PubMed ID: 16404705
    [Abstract] [Full Text] [Related]

  • 15. The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase.
    Li L, Zeng H, Shan L, Yuan X, Li Y, Liu R, Zhang W.
    J Ethnopharmacol; 2012 Sep 28; 143(2):732-9. PubMed ID: 22884869
    [Abstract] [Full Text] [Related]

  • 16. Sulfidopeptide-leukotrienes are major mediators of arachidonic acid-induced mouse ear edema.
    Inoue H, Mori T, Koshihara Y.
    Prostaglandins; 1988 Nov 28; 36(5):731-9. PubMed ID: 3148965
    [Abstract] [Full Text] [Related]

  • 17. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
    McMillan RM, Spruce KE, Crawley GC, Walker ER, Foster SJ.
    Br J Pharmacol; 1992 Dec 28; 107(4):1042-7. PubMed ID: 1334748
    [Abstract] [Full Text] [Related]

  • 18. Pharmacology of the pyrroloimidazole, SK&F 105809--II. Antiinflammatory activity and inhibition of mediator production in vivo.
    Griswold DE, Marshall PJ, Lee JC, Webb EF, Hillegass LM, Wartell J, Newton J, Hanna N.
    Biochem Pharmacol; 1991 Jul 25; 42(4):825-31. PubMed ID: 1907825
    [Abstract] [Full Text] [Related]

  • 19. A useful method for differential evaluation of anti-inflammatory effects due to cyclooxygenase and 5-lipoxygenase inhibitions in mice.
    Ishii K, Motoyoshi S, Kawata J, Nakagawa H, Takeyama K.
    Jpn J Pharmacol; 1994 Aug 25; 65(4):297-303. PubMed ID: 7990266
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.